Chapters
Skip to …
| Status | Drug name | NICE TAs | Comments | ||
|---|---|---|---|---|---|
|
Anagrelide capsules | ||||
|
Avatrombopag (Doptelet®) | ||||
|
Cyanocobalamin tablets | ||||
|
Danicopan |
|
|||
|
Darbepoetin alfa (Aranesp) |
NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323. |
|||
|
Deferasirox (Exjade) | ||||
|
Deferiprone tablets (Ferriprox) |
NHSE commissioned. |
|||
|
Desferrioxamine injection |
NHSE commissioned - NICE NG8. |
|||
|
Eculizumab (Bekemv®) | ||||
|
Eltrombopag tablets | ||||
|
Epoetin beta syringe (Neorecormon) |
NHSE commissioned renal dialysis. CCG Commissioned for use in cancer - NICE TA323. |
|||
|
Exagamglogene autotemcel (Casgevy®) |
|
|||
|
Fanhdi® | ||||
|
Ferric carboxymaltose injection (Ferinject) | ||||
|
Ferric maltol (Feraccru®) |
For the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD), unable to tolerate other oral iron formulations. Supported by a RICaD |
|||
|
Ferrous fumarate liquid | ||||
|
Ferrous fumarate tablets | ||||
|
Ferrous gluconate tablets |
If patient intolerant of sulphate. |
|||
|
Ferrous sulphate tablets |
High relative cost. |
|||
|
Filgastrim injection | ||||
|
Folic acid SF solution (Lexpex) | ||||
|
Folic acid tablets | ||||
|
Fostamatinib (Tavlesse®) | ||||
|
Hydroxocobalamin injection | ||||
|
Hydroxycarbamide capsules |
For use in sickle cell. |
|||
|
Iptacopan (Fabhalta®) |
|
|||
|
Iron (III) isomaltoside 1000 (Diafer) |
Under review. |
|||
|
Iron isomaltoside 1000 (Monofer) | ||||
|
Iron-hydroxide sucrose complex injection (Venofer) | ||||
|
Lenograstim injection | ||||
|
Lusutrombopag (Mulpleo®) | ||||
|
Methoxy polyethelene glycol-epoetin beta (Mircera) |
NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323. |
|||
|
Pegfilgrastim injection |
QEHB site only |
|||
|
Pregaday tablets | ||||
|
Ravulizumab (Ultomiris®) | ||||
|
Romiplostim injection | ||||
|
Sodium feredetate SF elixir | ||||
|
Vadadustat (Vafseo®) | ||||
|
Voxelotor |